Vancouver, British Columbia — November 4, 2025 — Leads & Copy —
Rise Health Nano Optics Inc. has been granted its third U.S. technology patent, U.S. Patent No. 12,383,955 (B2), strengthening its position in advanced eye-protection nanomaterials. The patent covers Rise’s proprietary nano-structured lens architecture designed to selectively filter harmful blue light and ultraviolet (UV) light while preserving visual clarity and color perception.
The company is preparing for U.S. product registration and market launch, with North American commercialization expected in Q4 2025, coinciding with its planned public listing on the Canadian Securities Exchange (CSE) under the ticker symbol “EYE”.
Founder and CEO of Rise Nano Optics, Inas Said, said the patent marks another milestone in Rise’s mission to transform preventative eye care through advanced nanotechnology and reinforces their leadership in optical innovation, accelerating the path to commercialization.
Rise specializes in nano-optic solutions that address preventable vision stress and eye disease. Its patented EYEGUARD™ technology targets the global eyewear market, with relevance to many degenerative eye diseases and diabetes-related vision impairments.
Investor Contacts: ir@risenanooptics.com
Source: Rise Health Nano Optics Inc.
